Rain Therapeutics Inc

NASDAQ:RAIN   3:59:58 PM EDT
19.49
-0.21 (-1.07%)
Other Pre-Announcement

Rain Therapeutics Reports First Quarter 2021 Financial Results And Highlights Recent Progress

Published: 05/25/2021 12:11 GMT
Rain Therapeutics Inc (RAIN) - Rain Therapeutics Reports First Quarter 2021 Financial Results and Highlights Recent Progress.
Q1 Loss per Share $1.93.
Rain Therapeutics - Expects Full Year 2021 Net Cash Used in Operating and Investing Activities to Be About $50.0 Million to $60.0 Million.
Rain Therapeutics -sees Projected Year End Cash Balance of About $137.0 Million to $147.0 Million in Cash and Cash Equivalents.